Bruce W. Bode
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Education
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmacology top 1%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Management and Research 207
- Diabetes Treatment and Management 55
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 7
- Genetics 14
- Diabetes and associated disorders 14
- Co-authors
- Satish K. Garg (29 shared papers)Richard M. Bergenstal (22 shared papers)Paul C. Davidson (12 shared papers)Timothy Silleck Bailey (27 shared papers)R. Dennis Steed (17 shared papers)FRANCINE RATNER KAUFMAN (16 shared papers)Irl B. Hirsch (21 shared papers)William V. Tamborlane (8 shared papers)
- Journals
- Diabetes Technology & Therapeutics (57 papers)Diabetes Care (35 papers)Diabetes (35 papers)Diabetes Obesity and Metabolism (16 papers)Endocrine Practice (14 papers)
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
Bruce W. Bode
264 papers receiving 20.1k citations
Bruce W. Bode's Hit Papers
Peers
Comparison fields: 5 of 152
- Endocrinology, Diabetes and Metabolism 17.1k
- Pharmacology 867
- Health Informatics 93
- Genetics 1.1k
- Nephrology 263
Countries citing papers authored by Bruce W. Bode
This map shows the geographic impact of Bruce W. Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce W. Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce W. Bode more than expected).
Fields of papers citing papers by Bruce W. Bode
This network shows the impact of papers produced by Bruce W. Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce W. Bode. The network helps show where Bruce W. Bode may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruce W. Bode, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 273 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2018 | 1445 |
| 2 | Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes Hit paper breakdown → | 2015 | 938 |
| 3 | Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial Hit paper breakdown → | 2008 | 913 |
| 4 | Exercise management in type 1 diabetes: a consensus statement Hit paper breakdown → | 2017 | 659 |
| 5 | The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System Hit paper breakdown → | 2015 | 566 |
| 6 | Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Hit paper breakdown → | 2023 | 559 |
| 7 | Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States Hit paper breakdown → | 2020 | 558 |
| 8 | Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes Hit paper breakdown → | 2016 | 506 |
| 9 | Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia Hit paper breakdown → | 2013 | 501 |
| 10 | Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes Hit paper breakdown → | 2017 | 475 |
| 11 | 2005 | 458 | |
| 12 | 2011 | 415 | |
| 13 | 2012 | 325 | |
| 14 | 2014 | 307 | |
| 15 | 2012 | 286 | |
| 16 | Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes Hit paper breakdown → | 2020 | 286 |
| 17 | International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors Hit paper breakdown → | 2019 | 275 |
| 18 | 2017 | 272 | |
| 19 | 2014 | 268 | |
| 20 | 2016 | 265 |
About Bruce W. Bode
Bruce W. Bode is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Physiology, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 273 papers that have together received 21.7k indexed citations. Recurring topics across this work include Diabetes Management and Research (207 papers), Diabetes Treatment and Management (55 papers), Diabetes and associated disorders (14 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers), Clinical Laboratory Practices and Quality Control (3 papers), Pharmacology and Obesity Treatment (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Retinal Imaging and Analysis (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (17.1k citations), Pharmacology (867 citations), Health Informatics (93 citations), Genetics (1.1k citations) and Nephrology (263 citations). Bruce W. Bode has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Satish K. Garg, Richard M. Bergenstal, Paul C. Davidson, Timothy Silleck Bailey, R. Dennis Steed, FRANCINE RATNER KAUFMAN, Irl B. Hirsch, William V. Tamborlane, Robert E. Ratner and Alan J. Garber. Their work appears in journals such as Diabetes Technology & Therapeutics, Diabetes Care, Diabetes, Diabetes Obesity and Metabolism and Endocrine Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.